Nationwide Fund Advisors Boosts Stake in Agilent Technologies, Inc. (A)
Nationwide Fund Advisors lifted its position in shares of Agilent Technologies, Inc. (NYSE:A) by 132.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 575,282 shares of the medical research company’s stock after buying an additional 327,822 shares during the quarter. Nationwide Fund Advisors owned about 0.18% of Agilent Technologies worth $36,933,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Advisor Group Inc. raised its stake in Agilent Technologies by 0.3% in the second quarter. Advisor Group Inc. now owns 3,959 shares of the medical research company’s stock valued at $235,000 after purchasing an additional 10 shares in the last quarter. Bronfman E.L. Rothschild L.P. raised its stake in Agilent Technologies by 0.8% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 4,658 shares of the medical research company’s stock valued at $276,000 after purchasing an additional 35 shares in the last quarter. Veritable L.P. raised its stake in Agilent Technologies by 0.4% in the second quarter. Veritable L.P. now owns 10,896 shares of the medical research company’s stock valued at $646,000 after purchasing an additional 40 shares in the last quarter. Balentine LLC raised its stake in Agilent Technologies by 2.9% in the second quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after purchasing an additional 50 shares in the last quarter. Finally, Kingfisher Capital LLC raised its stake in Agilent Technologies by 0.3% in the second quarter. Kingfisher Capital LLC now owns 22,643 shares of the medical research company’s stock valued at $1,343,000 after purchasing an additional 58 shares in the last quarter.
A number of research analysts recently commented on A shares. Zacks Investment Research raised Agilent Technologies from a “hold” rating to a “buy” rating and set a $74.00 price target for the company in a research note on Tuesday, October 10th. Deutsche Bank AG set a $68.00 price target on Agilent Technologies and gave the company a “buy” rating in a research note on Wednesday, August 16th. Janney Montgomery Scott boosted their price target on Agilent Technologies from $65.00 to $70.00 and gave the company a “buy” rating in a research note on Wednesday, August 16th. BidaskClub downgraded Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 9th. Five analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $68.20.
In other Agilent Technologies news, CFO Didier Hirsch sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of $64.00, for a total value of $1,280,000.00. Following the transaction, the chief financial officer now directly owns 183,002 shares of the company’s stock, valued at $11,712,128. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Boon Hwee Koh sold 4,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $63.63, for a total value of $286,335.00. The disclosure for this sale can be found here. Insiders sold 107,709 shares of company stock worth $7,195,576 over the last quarter.
Shares of Agilent Technologies, Inc. (NYSE A) opened at $68.69 on Friday. The firm has a market capitalization of $21,720.00, a PE ratio of 29.50, a PEG ratio of 2.76 and a beta of 1.28. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.76 and a current ratio of 3.30. Agilent Technologies, Inc. has a twelve month low of $42.92 and a twelve month high of $70.81.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.62 by $0.05. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.17 billion. Agilent Technologies had a return on equity of 15.05% and a net margin of 14.89%. The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.59 earnings per share. research analysts anticipate that Agilent Technologies, Inc. will post 2.57 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Investors of record on Tuesday, January 2nd will be issued a $0.149 dividend. The ex-dividend date of this dividend is Friday, December 29th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.13. This represents a $0.60 annualized dividend and a yield of 0.87%. Agilent Technologies’s dividend payout ratio is presently 25.24%.
COPYRIGHT VIOLATION WARNING: “Nationwide Fund Advisors Boosts Stake in Agilent Technologies, Inc. (A)” was reported by Watch List News and is the property of of Watch List News. If you are accessing this article on another publication, it was copied illegally and republished in violation of US and international copyright and trademark legislation. The legal version of this article can be viewed at https://www.watchlistnews.com/nationwide-fund-advisors-boosts-stake-in-agilent-technologies-inc-a/1723290.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.